Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.
Saved in:
| Title: | Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage. |
|---|---|
| Authors: | Azevedo RS; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Jabbour E; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Jain N; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Haddad FG; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kebriaei P; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Khouri I; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Shpall EJ; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Champlin R; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Karrar O; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Maroun M; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Senapati J; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kugler E; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Garris RS; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Ravandi F; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kantarjian H; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Short NJ; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA. nshort@mdanderson.org. |
| Source: | Leukemia [Leukemia] 2026 Jul 16. Date of Electronic Publication: 2026 Jul 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
